Japan Expands Influenza Testing Capabilities | Point-of-Care & Multiplex Diagnostics Drive Market Towards USD 0.3 Billion by 2033

Influenza Diagnostics Market is valued at at a promising CAGR during the forecast period (2024-2031).

The Influenza Diagnostics Market focuses on tools and technologies used to rapidly detect influenza viruses (A, B, and their subtypes). These diagnostics are vital for early disease management, outbreak control, and guiding antiviral treatment strategies. The market includes rapid influenza diagnostic tests (RIDTs), RT-PCR, immunoassays, and next-gen molecular diagnostics.

📌 Request Sample Report to Access Investor Opportunity Matrix -"Influenza Diagnostics Market"Deals & Growth Hotspots:- https://datamintelligence.com/download-sample/influenza-diagnostics-market?rk

☛ Influenza Diagnostics Market Recent Developments 2025:

United States: Recent Industry Developments
✅ In August 2025, the U.S. influenza diagnostics market is projected to grow from USD 2 billion in 2025 to USD 3.3 billion by 2032, driven by increasing flu prevalence and innovation in RT-PCR and NAATs.

✅ In May 2025, Abbott Laboratories secured a USD 314 million investment to enhance its influenza diagnostic solutions, emphasizing robust financial support for innovative diagnostic solutions.

✅ In July 2025, Quidel Corporation introduced a next-generation rapid influenza diagnostic test, incorporating advanced molecular technology to improve accuracy and reduce turnaround time.

Japan: Recent Industry Developments
✅ In June 2025, Japan's influenza A and B test kit market is projected to reach USD 0.3 billion by 2033, reflecting a growing demand for diagnostic solutions.

✅ In May 2025, Sekisui Diagnostics launched a multiplexed rapid influenza diagnostic test capable of detecting both influenza A and B strains simultaneously, enhancing diagnostic efficiency.

✅ In April 2025, Japan's Ministry of Health announced a nationwide initiative to expand point-of-care influenza testing in rural and underserved areas, aiming to improve early detection and treatment outcomes.

☛ Influenza Diagnostics Market Dynamics:

The Influenza Diagnostics market is experiencing strong growth driven by increasing seasonal flu outbreaks, heightened awareness of infectious disease management, and the ongoing need for rapid, accurate detection of influenza viruses. Rising adoption of point-of-care (POC) testing, molecular diagnostics, and rapid antigen tests allows healthcare providers to quickly identify influenza strains, improve patient outcomes, and implement timely interventions. The COVID-19 pandemic further emphasized the importance of influenza surveillance and robust diagnostic capabilities, boosting investment in advanced testing technologies.

Technological advancements in molecular assays, multiplex testing, and digital integration are enhancing test sensitivity, throughput, and data reporting. Expansion of diagnostic infrastructure in emerging markets, along with government initiatives for disease monitoring and vaccination campaigns, supports market growth. Additionally, the integration of automated platforms and portable testing devices facilitates faster diagnosis in hospitals, clinics, and remote locations, strengthening the global demand for influenza diagnostics.

☛ Influenza Diagnostics Market Major Companines and ROI Analysis:

Roche Diagnostics Limited, Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., 3M, Becton, Dickinson, and Company (BD), Hologic, Inc, Danaher Corporation, Biomeurex SA, Siemens Healthineers AG, QIAGEN.

Research Methodology

We employ a hybrid approach, integrating qualitative insights with robust quantitative analysis to deliver comprehensive and reliable market intelligence. The process starts with extensive secondary research, leveraging trusted industry publications, proprietary databases, and credible market sources. This foundation is then strengthened through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request Customized Market Entry Assessment for North America, EU, APAC: https://www.datamintelligence.com/customize/influenza-diagnostics-market

☛ Segment Covered in the Influenza Diagnostics Market:

By Disease Type: Type A Flu, Type B Flu, Type C Flu.

By Test Type: Traditional Diagnostic Test, Molecular Diagnostic Test.

By End User: Diagnostic Laboratories, Hospitals and Clinics, Research Labs, Others.

☛ This Report Covers:

✔ Comprehensive go-to-market strategy insights.

✔ An unbiased evaluation of market performance.

✔ In-depth analysis of development trends, competitive landscape, supply and demand dynamics, year-on-year growth, competitive benchmarking, vendor mapping, market access, and overall development status.

✔ Customized regional and country-level reports available on request, including detailed localized analysis.

✔ Identification of potential and niche segments/regions showcasing strong growth opportunities.

✔ Application of both top-down and bottom-up approaches for accurate regional market analysis.

📌 Get Corporate Access to Live Influenza Vaccines Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=influenza-diagnostics-market

☛ Regional Analysis for Influenza Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Influenza Diagnostics Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Influenza Diagnostics Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Influenza Diagnostics Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.